发明名称 Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
摘要 This disclosure provides methods and compositions for inhibiting immune responses. The disclosure also provides methods and compositions for inhibiting graft rejection and promoting or prolonging graft survival.
申请公布号 USRE46323(E1) 申请公布日期 2017.02.28
申请号 US201314080457 申请日期 2013.11.14
申请人 Alexion Pharmaceuticals, Inc. 发明人 Rother Russell P.;Faas McKnight Susan
分类号 A61K39/395;C07K16/28;A61K39/00 主分类号 A61K39/395
代理机构 Nelson Mullins Riley & Scarborough LLP 代理人 Nelson Mullins Riley & Scarborough LLP ;Remillard, Esq. Jane E.;Frank Christopher L.
主权项 1. A method of inhibiting an immune response in a subject who has received or will receive a cell, tissue, or organ transplant, wherein said method comprises administering to the subject an effective amount of i) an agent which inhibits interaction between CD200 and CD200R and ii) an immunosuppressive id="REI-00012" date="20170228" orid="REI-00012" drug, wherein the agent is an anti-CD200 antibody, or antigen-binding fragment thereof, exhibiting reduced effector function.
地址 New Haven CT US